Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response

Nat Commun. 2024 Jan 2;15(1):180. doi: 10.1038/s41467-023-44239-2.

Abstract

Inactivating TP53 mutations leads to a loss of function of p53, but can also often result in oncogenic gain-of-function (GOF) of mutant p53 (mutp53) proteins which promotes tumor development and progression. The GOF activities of TP53 mutations are well documented, but the mechanisms involved remain poorly understood. Here, we study the mutp53 interactome and find that by targeting minichromosome maintenance complex components (MCMs), GOF mutp53 predisposes cells to replication stress and chromosomal instability (CIN), leading to a tumor cell-autonomous and cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING)-dependent cytosolic DNA response that activates downstream non-canonical nuclear factor kappa light chain enhancer of activated B cell (NC-NF-κB) signaling. Consequently, GOF mutp53-MCMs-CIN-cytosolic DNA-cGAS-STING-NC-NF-κB signaling promotes tumor cell metastasis and an immunosuppressive tumor microenvironment through antagonizing interferon signaling and regulating genes associated with pro-tumorigenic inflammation. Our findings have important implications for understanding not only the GOF activities of TP53 mutations but also the genome-guardian role of p53 and its inactivation during tumor development and progression.

MeSH terms

  • Chromosomal Instability / genetics
  • DNA
  • Humans
  • Interferons / metabolism
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Neoplasms* / genetics
  • Nucleotidyltransferases / metabolism
  • Tumor Microenvironment
  • Tumor Suppressor Protein p53* / genetics
  • Tumor Suppressor Protein p53* / metabolism

Substances

  • Tumor Suppressor Protein p53
  • NF-kappa B
  • DNA
  • Nucleotidyltransferases
  • Interferons